PMD Psychemedics Corporation logo

PMD Psychemedics Corporation

Healthcare
$2.67+0.00%ClosedMarket Cap: $15.6M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

3.05

P/S

0.79

EV/EBITDA

80.17

DCF Value

$1.90

FCF Yield

5.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

36.1%

Operating Margin

-9.6%

Net Margin

-9.5%

ROE

-31.5%

ROA

-22.4%

ROIC

-29.2%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 null$4.4M$189.0K$
FY null$19.7M$-1.9M$
Q3 null$5.2M$-535.0K$
Q2 null$4.7M$-827.0K$

Analyst Ratings

View All

Consensus

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Powell Anderson Capital Partners LLC10 percent owner
BuyTue Dec 17
Powell Anderson Capital Partners LLC10 percent owner
BuyTue Dec 17
Powell Anderson Capital Partners LLC10 percent owner
BuyTue Dec 17
Powell Anderson Capital Partners LLC10 percent owner
BuyThu Dec 12
Powell Anderson Capital Partners LLC10 percent owner
BuyThu Dec 12

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

Beta

0.67

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.

Peers